AdvaMed strongly supports creation of an alternative, expedited pathway to coverage and payment for emerging devices and diagnostics. Transitional coverage for these technologies would bolster the innovation ecosystem and provide Medicare patients’ swift access to new technologies that existing therapies may be unable to address. A recent study by the Stanford Byers Center for Biodesign found it takes an average of five years for medical technologies to achieve nationwide coding, coverage, and payment. This delay not only impacts patients, but also increases costs, which flow through the entire healthcare system.

The Centers for Medicare & Medicaid Services (CMS) is working with industry stakeholders, including medical device companies, as well as physician societies and patient groups to develop an alternate pathway called Transitional Coverage for Emerging Technologies (TCET).

Medicare beneficiaries deserve access to new and innovative medical technologies as soon as possible.

Benefits of Improved Access to New Technologies

What the Experts Say

Learn More

Contribute to AdvaMed PAC

Our voluntary, bi-partisan Political Action Committee (PAC) allows us to maximize the political strength of the medical device industry. Please consider making a contribution.